Physician Sample (Combination Product Physician Sample)
Furoscix Injection
Product Images NDC 71767-100
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Furoscix (NDC 71767-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Scpharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Combination Product Primary Carton (Combination Product Primary Carton)
Tyvek Lid (Device Tyvek Lid)
The text is a description of an on-body infusor specifically designed for subcutaneous use in the administration of 80mg/10mL furosemide injection. The brand name of the infusor is FUROSCIX® designed by scPharmaceuticals®. The infusor uses a cylindrical lithium battery and can withstand temperature up to 104°F and 90% humidity. It is manufactured by scPharmaceuticals Inc. located in Massachusetts, USA. The text also includes some technical details like battery type, manufacturing code, usage instructions, etc. Overall, the text is a useful description of the INFUSOR, FUROSCIX®, including its components, uses, and manufacturer.*
Device Pad (Device)
The text is a description of an On-Body Infusor for a medication called FUROSCIX S TRmeCias (furosemide injection) which has a concentration of 80mg per 10mL (8mg per mL). The phone number 1-855-727-4276 is also provided for potential customer service inquiries.*
Cartridge Carton (Drug Product Cartridge Carton)
This is a product label for a medication called Furoscix, which has a concentration of 80mg/10ml. The medication is for subcutaneous use only and is manufactured by ScPharmaceuticals Inc. The label provides instructions for storage and use and includes a warning to protect from light and use only the approved specifications. The label also lists the active ingredients as sodium chloride and hydrochloride.*
Cartridge (Drug Product Cartridge)
FUROSCIX is a medication in the form of furosemide injection, with a concentration of 80mg/10mL (8mg/mL), and packed in a 10 mL single-dose cartridge. It is designed to be used subcutaneously and should be protected from light. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F). It is manufactured by scPharmaceuticals Inc. The identification code is LOT 12345 with expiry date mentioned as YYYY-MMM-DD.*
Figure A (Figure A)
This appears to be a partial image or diagram of a white tab with an adhesive liner, accompanied by a pre-filled cartridge with a tip and a small window. The image also includes a cartridge holder. Without further context, it is difficult to determine the exact purpose or application of these objects.*
Figure B (Figure B)
C (Figure C)
D (Figure D)
E (Figure E)
F (Figure F)
G (Figure G)
H (Figure H)
I (Figure I)
J (Figure J)
K (Figure K)
The text describes an image or figure labeled as "Figure K" that illustrates a cartridge tip pointing downward inside a cartridge holder.*
L (Figure L)
M (Figure M)
N (Figure N)
O (Figure O)
P (Figure P)
Q (Figure Q)
R (Figure R)
S (Figure S)
T (Figure T)
U (Figure U)
V (Figure V)
W (Figure W)
X (Figure X)
Structure (Furosemide Structure)
Symb (Ifu Symbols)
Symbols Legend with various markings revealing different meanings for instructions of use, single use, expiration date, non-pyrogenic, temperature limitation, manufacturer's name and federal law restrictions. There is a warning to not use the product after the package has been opened or damaged. Additional information includes the catalog, serial, and lot numbers, humidity and atmospheric limitations. The product has been sterilized by ethylene oxide and cannot be used during an MRI procedure due to it being unsafe. Lastly, the product should be kept dry.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
